Barclays PLC Nevro Corp Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Nevro Corp stock. As of the latest transaction made, Barclays PLC holds 61,496 shares of NVRO stock, worth $244,139. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,496

Previous 61,496 -0.0%

Holding current value

$244,139

Previous $344,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$4.71 - $10.1 $416,919 - $894,031	-88,518 Reduced 59.01%	61,496 $344,000
Q2 2024 Aug 14, 2024	SELL	$7.96 - $13.59 $419,269 - $715,812	-52,672 Reduced 25.99%	150,014 $1.26 Million
Q1 2024 May 15, 2024	BUY	$13.56 - $20.78 $1.9 Million - $2.91 Million	139,900 Added 222.82%	202,686 $2.93 Million
Q4 2023 Feb 15, 2024	BUY	$14.18 - $22.31 $640,283 - $1.01 Million	45,154 Added 256.09%	62,786 $1.35 Million
Q3 2023 Nov 07, 2023	BUY	$18.22 - $25.85 $75,303 - $106,838	4,133 Added 30.62%	17,632 $339,000
Q2 2023 Aug 03, 2023	SELL	$22.62 - $39.32 $191,319 - $332,568	-8,458 Reduced 38.52%	13,499 $343,000
Q1 2023 May 04, 2023	BUY	$30.17 - $41.11 $359,505 - $489,866	11,916 Added 118.67%	21,957 $794,000
Q4 2022 Feb 13, 2023	BUY	$36.43 - $49.4 $261,458 - $354,543	7,177 Added 250.59%	10,041 $397,000
Q3 2022 Nov 03, 2022	BUY	$40.66 - $53.03 $35,292 - $46,030	868 Added 43.49%	2,864 $134,000
Q2 2022 Aug 12, 2022	SELL	$40.85 - $77.67 $202,125 - $384,311	-4,948 Reduced 71.26%	1,996 $88,000
Q1 2022 May 16, 2022	SELL	$59.95 - $92.06 $7.31 Million - $11.2 Million	-121,864 Reduced 94.61%	6,944 $503,000
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $7.09 Million - $10.6 Million	87,424 Added 211.25%	128,808 $10.4 Million
Q3 2021 Nov 09, 2021	BUY	$101.99 - $166.36 $1.76 Million - $2.86 Million	17,220 Added 71.26%	41,384 $4.82 Million
Q2 2021 Aug 13, 2021	SELL	$141.6 - $179.06 $3 Million - $3.79 Million	-21,166 Reduced 46.69%	24,164 $4.01 Million
Q1 2021 May 13, 2021	BUY	$132.81 - $182.18 $2.59 Million - $3.55 Million	19,513 Added 75.58%	45,330 $6.32 Million
Q4 2020 Feb 11, 2021	SELL	$138.17 - $184.34 $1.06 Million - $1.41 Million	-7,649 Reduced 22.86%	25,817 $4.47 Million
Q3 2020 Nov 12, 2020	BUY	$114.09 - $145.51 $346,833 - $442,350	3,040 Added 9.99%	33,466 $4.66 Million
Q2 2020 Aug 12, 2020	BUY	$89.45 - $129.85 $1.81 Million - $2.63 Million	20,232 Added 198.47%	30,426 $3.64 Million
Q1 2020 May 13, 2020	SELL	$70.23 - $144.31 $1.39 Million - $2.85 Million	-19,742 Reduced 65.95%	10,194 $1.02 Million
Q4 2019 Feb 10, 2020	BUY	$76.41 - $117.54 $75,111 - $115,541	983 Added 3.4%	29,936 $3.52 Million
Q3 2019 Nov 14, 2019	BUY	$61.52 - $91.1 $608,063 - $900,432	9,884 Added 51.83%	28,953 $2.49 Million
Q2 2019 Aug 14, 2019	BUY	$58.04 - $66.99 $601,874 - $694,686	10,370 Added 119.21%	19,069 $1.24 Million
Q1 2019 May 15, 2019	BUY	$35.52 - $62.62 $180,192 - $317,671	5,073 Added 139.91%	8,699 $543,000
Q4 2018 Feb 14, 2019	SELL	$35.43 - $56.29 $1.63 Million - $2.59 Million	-46,004 Reduced 92.69%	3,626 $141,000
Q3 2018 Nov 14, 2018	BUY	$44.22 - $75.47 $2.1 Million - $3.58 Million	47,498 Added 2227.86%	49,630 $2.83 Million
Q2 2018 Aug 14, 2018	SELL	$72.38 - $92.5 $718,805 - $918,617	-9,931 Reduced 82.33%	2,132 $170,000
Q1 2018 May 15, 2018	SELL	$69.46 - $88.57 $711,409 - $907,133	-10,242 Reduced 45.92%	12,063 $1.05 Million
Q4 2017 Feb 14, 2018	BUY	$65.94 - $93.31 $1.34 Million - $1.9 Million	20,338 Added 1033.96%	22,305 $1.54 Million
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $159,071 - $179,154	1,967	1,967 $178,000

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $140M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account